reviewAnnals of OncologyMar 22, 2016Closed access

IDH mutations in cancer and progress toward development of targeted therapeutics

LDLenny DangKYKatharine YenECEyal C. Attar

Agios Pharmaceuticals (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

517
total citations
FWCI
36.15
Percentile
100%
References
105
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Isocitrate dehydrogenase
  • IDH1
  • IDH2
  • Cancer research
  • Epigenetics
  • Myeloid leukemia
  • Myelodysplastic syndromes
  • Carcinogenesis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.